Alnylam Canada Signs LOI From Pan-Canadian Pharmaceutical Alliance For The Public Reimbursement Of AMVUTTRA For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults

BenzingaOct 18 08:17 ET

Express News | Alnylam Canada Signs Letter of Intent From Pan-Canadian Pharmaceutical Alliance for the Public Reimbursement of Amvuttra® for the Treatment of Hereditary Transthyretin-Mediated (Hattr) Amyloidosis in Adults

ReutersOct 18 08:15 ET

H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400

Moomoo NewsOct 17 11:31 ET · Ratings

Press Release: Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

Dow JonesOct 17 08:05 ET

Alnylam to Webcast Conference Call Discussing Third Quarter 2024 Financial Results

Alnylam Pharmaceuticals, Inc.Oct 17 00:00 ET

JAZZ Stock Soars After Combo Therapy Meets Goal in Lung Cancer Study

Zacks Oct 16 10:05 ET